Please try another search
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.
Name | Age | Since | Title |
---|---|---|---|
Yunzhong Zhou | 59 | - | GM & Vice Chairman |
Yuxiang Wu | 54 | 2021 | Executive Deputy GM, CFO & Director |
Ling Ma | 52 | 2021 | Independent Director |
Jianqiao Zhang | 49 | 2021 | Non-Independent Director |
Qiaogen Feng | 62 | 2021 | Independent Director |
Jian Qin | 49 | 2021 | Non-Employee Supervisor |
Xu Wang | 72 | 2021 | Independent Director |
Hongyu Yin | 50 | 2019 | Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review